Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Jinxin Fertility Group Ltd. ( (HK:1951) ) just unveiled an update.
Jinxin Fertility Group Ltd. has announced its upcoming annual general meeting scheduled for June 26, 2025, in Chengdu, China. The meeting will address several key resolutions, including the adoption of the 2024 financial statements, re-election of directors, and re-appointment of Deloitte Touche Tohmatsu as auditors. Additionally, the company seeks shareholder approval to authorize the board to issue new shares and fix director remuneration, indicating a focus on strategic growth and governance.
The most recent analyst rating on (HK:1951) stock is a Buy with a HK$3.33 price target. To see the full list of analyst forecasts on Jinxin Fertility Group Ltd. stock, see the HK:1951 Stock Forecast page.
More about Jinxin Fertility Group Ltd.
Jinxin Fertility Group Ltd. operates in the healthcare industry, focusing on fertility services. The company provides a range of reproductive medical services, including in vitro fertilization and other assisted reproductive technologies, primarily targeting the Chinese market.
Average Trading Volume: 108,370,123
Technical Sentiment Signal: Sell
Current Market Cap: HK$7.52B
See more insights into 1951 stock on TipRanks’ Stock Analysis page.